Non-Surgical Management of Advanced Squamous Cell Carcinoma by a Novel Agent

Mon statut pour la session

Quoi:
Paper Presentation | Présentation d'article
Partie de:
Recherche de pointe en oculoplastie !
Quand:
2:02 PM, Vendredi 10 Juin 2022 (7 minutes)
Où:
Halifax Convention Centre - C2
Thème:
Oculoplastie

Authors: Ryan Eidsness, Malshi Kurunatilake, Mussawar Iqbal. University of Saskatchewan.

Author Disclosure Block: R. Eidsness: None. M. Kurunatilake: None. M. Iqbal: None

Abstract Body:

Purpose: Discuss a case of advanced Squamous cell carcinoma (SCC) involving the eyelid, conjunctiva, and orbit that responded to Cemiplimab (Libtayo)

Study Design: Study design: Case Study

Methods: A case study of advanced SCC involving eyelids, conjunctiva and orbit was selected for evaluation. The clinical course of outcomes with follow up of >12 months from treatment conclusion are presented
Results: With the use of cemiplimab the eyelid and orbital component of the SCC completely resolved with the cemiplimab and has remained tumor free for >12 months time. The conjunctival component was aided with the use of topical interferon as well as retinoic acid.

Conclusions: We were able to avoid a large disfiguring exenteration and thus salvage the globe and preserve functional vision in the right eye.
 

Dr. Ryan Eidsness
Conférencier.ère

Mon statut pour la session

Évaluer

Detail de session
Pour chaque session, permet aux participants d'écrire un court texte de feedback qui sera envoyé à l'organisateur. Ce texte n'est pas envoyé aux présentateurs.
Afin de respecter les règles de gestion des données privées, cette option affiche uniquement les profils des personnes qui ont accepté de partager leur profil publiquement.

Les changements ici affecteront toutes les pages de détails des sessions